Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "intercellular adhesion molecule pseudogene" (ENSG00000259333) is a genomic sequence classified as a pseudogene, meaning it closely resembles functional intercellular adhesion molecule (ICAM) genes but has been rendered nonfunctional by mutation or duplication events[1][3][5]. Pseudogenes do not code for functional proteins and are considered genomic relics produced by evolutionary processes. This entry may be homologous to genes such as ICAM1 or ICAM3 but lacks promoter activity and protein-coding ability. Pseudogenes sometimes produce noncoding RNAs with regulatory roles, although no such activity has been documented for ENSG00000259333[1][3]. These sequences may confound genetic assays but are generally not of therapeutic relevance.
None. As this pseudogene does not encode a protein or functional RNA, it does not have a mechanism of action relevant to drug targeting[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intercellular adhesion molecule pseudogene.